XML 26 R44.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note 9 - Segment Information - Operating Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Biological Indicators [Member]        
Revenues $ 8,482 $ 6,441 $ 15,718 $ 12,858
Gross profit 5,539 4,051 10,288 7,835
Selling expenses 507 368 867 772
Gross profit after deducting selling expense and impairment of intangible asset $ 5,032 $ 3,683 $ 9,421 $ 7,063
Reconciling items (1) [1] [1]
Earnings before income taxes
Instruments [Member]        
Revenues $ 9,228 $ 9,065 $ 17,559 $ 16,750
Gross profit 5,705 5,455 11,060 10,382
Selling expenses 1,210 829 2,191 1,821
Gross profit after deducting selling expense and impairment of intangible asset $ 4,495 $ 4,626 $ 8,869 $ 8,561
Reconciling items (1) [1] [1]
Earnings before income taxes
Continuous Monitoring [Member]        
Revenues $ 2,226 $ 3,034 $ 4,817 $ 5,332
Gross profit 955 1,617 1,992 2,611
Selling expenses 508 145 966 812
Gross profit after deducting selling expense and impairment of intangible asset $ 447 $ 1,472 $ 1,026 $ 1,799
Reconciling items (1) [1] [1]
Earnings before income taxes
Cold Chain [member]        
Revenues $ 1,840   $ 1,840  
Gross profit 868   868  
Selling expenses 63   63  
Gross profit after deducting selling expense and impairment of intangible asset $ 805   $ 805  
Reconciling items (1) [1] [1]
Earnings before income taxes
Revenues $ 21,776 $ 18,540 $ 39,934 $ 34,940
Gross profit 13,067 11,123 24,208 20,828
Selling expenses 2,288 1,342 4,087 3,405
Gross profit after deducting selling expense and impairment of intangible asset 10,779 9,781 20,121 17,423
Reconciling items (1) (7,986) [1] (5,038) [1] (13,802) (9,787)
Earnings before income taxes $ 2,793 $ 4,743 $ 6,319 $ 7,636
[1] Reconciling items include general and administrative, research and development, and other expenses.